The board of Epix Pharmaceuticals (NASDAQ:[[ticker:EPIX]]) has appointed Elkan Gamzu to be its CEO, after the 35-year life sciences industry veteran served as interim chief executive beginning last summer, according to the company. Gamzu, 66, took over the CEO role at Lexington, MA-based Epix vacated by former Epix CEO Michael Kauffman, who resigned in July 2008 after a series of clinical and regulatory setbacks at the firm during his two-year tenure.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
